It was another case of just trying to outsource it with a $20K government grant imo - of course possibly a "potential sleeper" but who knows. They've also pushed PYC35 back to Bio-Link following Le Metier Tribeca's bankruptcy put forward in the last update but as it was a non-exclusive license it could of been out-licensed at any time regardless it wasn't blocking any other parties.
PYCAG5 looked good for TBI with preclinical proof of concept but that's been over 3 years since they published PoC & started trying to partner / out-license it.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.000(0.00%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.43 | $1.37 | $119.5K | 85.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 948 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 2467 | 2 |
View Market Depth
| Last trade - 14.23pm 15/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |